Gene therapy in autoimmune disease
- 18 October 2001
- journal article
- review article
- Published by Elsevier in Current Opinion in Immunology
- Vol. 13 (6) , 676-682
- https://doi.org/10.1016/s0952-7915(01)00278-3
Abstract
No abstract availableKeywords
This publication has 53 references indexed in Scilit:
- Dendritic cells genetically engineered to express IL-4 inhibit murine collagen-induced arthritisJournal of Clinical Investigation, 2001
- A gene therapy approach for treating T-cell–mediated autoimmune diseasesBlood, 2001
- Degradable polymeric carrier for the delivery of IL-10 plasmid DNA to prevent autoimmune insulitis of NOD miceGene Therapy, 2000
- Bone marrow-derived cells as carriers of recombinant immunomodulatory cytokine genes to lymphoid organsCancer Gene Therapy, 2000
- Treatment of murine lupus with cDNA encoding IFN-γR/FcJournal of Clinical Investigation, 2000
- IL-4 gene therapy for collagen arthritis suppresses synovial IL-17 and osteoprotegerin ligand and prevents bone erosionJournal of Clinical Investigation, 2000
- Antigen presenting cells expressing Fas ligand down-modulate chronic inflammatory disease in Fas ligand–deficient miceJournal of Clinical Investigation, 2000
- A20 Inhibits Cytokine-Induced Apoptosis and Nuclear Factor κB–Dependent Gene Activation in IsletsThe Journal of Experimental Medicine, 1999
- Prevention of autoimmune diabetes by intramuscular gene therapy with a nonviral vector encoding an interferon-gamma receptor/IgG1 fusion proteinGene Therapy, 1999
- CTLA-4 can function as a negative regulator of T cell activationImmunity, 1994